| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1018042438 |
| P356 | DOI | 10.1038/328731A0 |
| P698 | PubMed publication ID | 3614380 |
| P50 | author | Sally Roberts | Q42527694 |
| P2093 | author name string | Rees AR | |
| Cheetham JC | |||
| P433 | issue | 6132 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| P304 | page(s) | 731-734 | |
| P577 | publication date | 1987-08-01 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | Generation of an antibody with enhanced affinity and specificity for its antigen by protein engineering | |
| P478 | volume | 328 |
| Q36878038 | 1 Modeling of antibody combining sites |
| Q36878010 | 2 Computer modeling of combining site structure of anti-hapten monoclonal antibodies |
| Q67805763 | 3 Protein engineering of single-chain Fv analogs and fusion proteins |
| Q36878003 | 9 Use of two-dimensional 1H nuclear magnetic resonance to study high-affinity antibody-peptide interactions |
| Q61651734 | A humanized monovalent CD3 antibody which can activate homologous complement |
| Q32044512 | Antibody fragments as inhibitors of Japanese radish acid phosphatase |
| Q30358772 | Antigen mobility in the combining site of an anti-peptide antibody. |
| Q44990091 | Cooperative effects of mutations in a recombinant Fab on the kinetics of antigen binding |
| Q38089136 | Developing novel biopharmaceutical products through morphogenics |
| Q41538464 | Differences in antigen-binding affinity caused by a single amino acid substitution in the variable region of the heavy chain |
| Q30009044 | Directed Evolution of a Highly Specific FN3 Monobody to the SH3 Domain of Human Lyn Tyrosine Kinase |
| Q38323258 | Efficient production of a functional single-chain antidigoxin antibody via an engineered Bacillus subtilis expression-secretion system |
| Q41641536 | Genetic engineering of high affinity anti-human colorectal tumour mouse/human chimeric antibody |
| Q41521066 | Heavy chain position 50 is a determinant of affinity and specificity for the anti-digoxin antibody 26-10 |
| Q38672137 | Imaging with radiolabelled monoclonal antibodies |
| Q35237160 | Immortalisation of human antibody producing cells |
| Q34423748 | Immunochemistry of DNA. |
| Q37624015 | Man-made antibodies |
| Q36767989 | Medical applications of single-chain antibodies |
| Q34322701 | Modeling antibody hypervariable loops: a combined algorithm. |
| Q74027625 | Modeling of the TCR-MHC-peptide complex |
| Q38308372 | Molecular recognition of a Salmonella trisaccharide epitope by monoclonal antibody Se155-4. |
| Q40851383 | Novel approaches to the preparation and use of monoclonal antibodies |
| Q37975455 | Novel intravenous immunoglobulins and their applications |
| Q41568249 | Nucleotide sequence analysis of CDR3 elements of a panel of anti-peptide monoclonal antibodies recognizing parathyroid hormone-related protein. |
| Q45872951 | Ofatumumab Monoclonal Antibody Affinity Maturation Through in silico Modeling |
| Q33192279 | Protein engineering of antibodies |
| Q34296709 | Protein evolution on rugged landscapes |
| Q46979502 | Recombinant Antibody Technolgy |
| Q40771987 | Recombinant antibody technology: its advent and advances |
| Q28290936 | Reshaping human antibodies for therapy |
| Q33712484 | Serum half-life and tumor localization of a chimeric antibody deleted of the CH2 domain and directed against the disialoganglioside GD2 |
| Q42417730 | Stacking and energetic contribution of aromatic islands at the binding interface of antibody proteins |
| Q33646218 | Structural correlates of high antibody affinity: three engineered amino acid substitutions can increase the affinity of an anti-p-azophenylarsonate antibody 200-fold |
| Q27643117 | Structure of a human monoclonal antibody Fab fragment against gp41 of human immunodeficiency virus type 1 |
| Q100694262 | Structure-based design and discovery of novel anti-tissue factor antibodies with cooperative double-point mutations, using interaction analysis |
| Q41607388 | The His-probe method: effects of histidine residues introduced into the complementarity-determining regions of antibodies on antigen-antibody interactions at different pH values |
| Q40451204 | The biotechnology and applications of antibody engineering. |
| Q30374518 | Thermodynamics of antibody-antigen interaction revealed by mutation analysis of antibody variable regions. |
| Q41448726 | Trials and tribulations: oncological antibody imaging comes to the fore |
| Q37924787 | Use of deuterium labelling in NMR studies of antibody combining site structure |
| Q37414421 | Virus neutralization by germ-line vs. hypermutated antibodies |
Search more.